BTAX — Biostax Share News
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
Brief: Biostax Corp. And Statera Biopharma Inc Reach Mutually Beneficial Dispute Settlement And Amended License Agreement Providing Clearer Clinical And Commercial Pathways For Both Companies
Brief: Immune Therapeutics Inc Announces Management Change
Brief: Statera Biopharma And Immune Therapeutics Inc. Announce Strategic Agreement For Rights To Low Dose Naltrexone
Brief: Immune Therapeutics Today Announces Appointment Of Michael Handley As Its New Chief Executive Officer And Member Of The Board Of Directors
Brief: Immune Therapeutics Says Kenya Pharmacy & Poison Board Filed Co's NDA For Lodona, Thereby Accepting NDA For Full Review
Brief: Immune Therapeutics Updates on CEO Search Plans